ANI
23 Feb 2021, 22:25 GMT+10
Mumbai (Maharashtra) [India], February 23 (ANI): The sale of 'Coronil', Patanjali's Covid-19 medicine will not be allowed in Maharashtra without proper certification, state Home Minister Anil Deshmukh said on Tuesday.
Without taking names, Deshmukh also hit out at Union ministers Dr Harsh Vardhan and Nitin Gadkari for hurriedly launching the product and called it 'deplorable'.
"Launching such a drug hurriedly and being endorsed by two senior Central Union Ministers is highly deplorable," Deshmukh tweeted.
Selling of Coronil without proper certification from competent health organizations like WHO, IMA and others will not be allowed in Maharashtra, he said.
"The IMA (Indian Medical Association) has questioned the said 'clinical trials' of Coronil and WHO refuted the false claims made by Patanjali Ayurveda for giving any certificate regarding its effectiveness for Covid-19 treatment," the state home minister tweeted.
On Monday, the Indian Medical Association (IMA) had demanded an explanation from the Union Health Minister for promoting Patanjali's 'medicine'.
"Being a Health Minister of the country, how justified is it to release such falsely fabricated unscientific product to people of the whole country and how ethical is it to promote the product in unethical, wrong and false ways?" asked Dr Jayalal, IMA national president.
Coronil was licensed as an "immunity booster" in June last year after a controversy erupted after its launch.
"When we launched Coronil, people raised questions on its validity and asked if we followed scientific parameters. People think research can only happen in foreign countries. With this research, we have cleared all suspicions about Coronil," said Ramdev while speaking at the launch of the product on Friday.
The Yoga Guru had also made claims that the medicine had received clearance from the World Health Organization (WHO) and they were now ready to supply the drug across the country.
The World Health Organization (WHO), however, clarified in a tweet that it has not reviewed or certified the efficacy of Patanjali's Covid-19. The WHO's regional office for South-East Asia posted on its official Twitter handle said, "@WHO has not reviewed or certified the effectiveness of any traditional medicine for the treatment Covidl9." (ANI)Get a daily dose of Asia Pacific Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Asia Pacific Star.
More InformationBEIJING, China: China's national soccer team may struggle to stir excitement, but its humanoid robots are drawing cheers — and not...
]LONDON, U.K.: A World Health Organization (WHO) expert group investigating the origins of the COVID-19 pandemic released its final...
FRANKFURT, Germany: Germany has become the latest country to challenge Chinese AI firm DeepSeek over its data practices, as pressure...
BANGKOK, Thailand: This week, Thailand implemented land border restrictions, including a ban on tourists traveling to Cambodia, as...
Aluminum, copper and nickel shipments have surged this year, according to trade data Beijing has increased purchases of Russian metals...
New Delhi [India], July 1 (ANI): The Ministry of External Affairs on Tuesday announced the appointment of Jayant Khobragade of the...
NEW YORK, New York - Global stock indices closed with divergent performances on Tuesday, as investors weighed corporate earnings, central...
TORONTO, Canada: Canadian Prime Minister Mark Carney announced late on June 29 that trade negotiations with the U.S. have recommenced...
Vancouver, Canada: A high-stakes legal showdown is brewing in the world of athleisure. Lululemon, the Canadian brand known for its...
LONDON, U.K.: British oil giant Shell has denied reports that it is in talks to acquire rival oil company BP. The Wall Street Journal...
NEW YORK, New York - U.S. stock markets closed firmly in positive territory to start the week Monday, with the S&P 500 and Dow Jones...
WASHINGTON, D.C.: On Friday, President Donald Trump announced that he was halting trade discussions with Canada due to its decision...